DU176B-A-U157: A Phase 1, Open-label, Single-dose, Non-randomized Study to Evaluate Pharmacokinetics (PK) and Pharmacodynamics (PD) of Edoxaban in Pediatric Patients.

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/157/31/17

Funding

  • Daiichi-Sankyo Pharma Development